Entero Healthcare Solutions Share Price

Entero Healthcare Solutions Limited was incorporated as Entero Healthcare Solutions Private Limited dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, at New Delhi. Subsequently, the Company was converted into a public limited company and the name of the Company was changed to Entero Healthcare Solutions Limited, and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.The Company was founded in 2018 by Prabhat Agrawal, the Promoter to create an organized, panIndia, technology driven and integrated healthcare products distribution platform that can add value to the entire healthcare ecosystem. The Company is the authorized distributor for most of the top pharmaceutical companies in India. It also has strategic supply relationship with some of the leading corporate hospital chains of the country, The Companys primary line of business is in the distribution of healthcare products to retail pharmacies, hospitals and healthcare clinics in India. The Company acquired 100% shareholding in Novacare Healthcare Solutions Private Limited, making it a wholly owned subsidiary in 2018. In 2022, SS Pharma Traders Private Limited was acquired by the Company, making it a wholly owned subsidiary of the Company. In 2023, Entero R.S. Enterprises Limited and Dhanvanthri Super Speciality Private Limited were acquired as 100% subsidiary of the Company. The Company came up with an IPO of issuing 12,725,244 equity shares of Rs 10 each by raising capital aggregating to Rs 1600 Cr, comprising a fresh issue of 7,955,769 equity shares of Rs 1000 Cr and offer for sale of 4,769,475 equity shares to Rs 600 Cr in February, 2024.Company expanded the product portfolio by managing over 80,600 SKUs sourced through 2700 healthcare product manufacturers in FY25 a notable increase from 68,900+ in FY24. It has built an unparalleled infrastructure backbone consisting of 101 warehouses across 20 states, catering to over 95,300 retail pharmacies and more than 3,600 hospitals in 2025. In FY 2025, Company acquired 80% of the shareholding of Avenir Lifecare Pharma Private Limited and Gourav Medical Agencies Private Limited each, 60% of the shareholding of Peerless Biotech Pharma Private Limited, 70% of the shareholding of Sai Pharma Distributors Private Limited and Srinivasa Lifecare Private Limited each, making them Subsidiaries of the Company. It acquired 100% of the shareholding of Suprabhat Pharmaceuticals Private Limited, Devi Pharma Wellness Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited, making them whollyowned Subsidiaries of the Company.

For the full year FY2026–2027, revenue reached ₹6610.45 crore and profit touched at ₹145.84 crore. As of Mar '26, Entero Healthcare Solutions’s market capitalisation stood at ₹4,947.10 crores. Shareholding as of Mar '26 shows promoters holding 52.4%, with FIIs at 4%, DIIs at 16.6%, and public at 26.9%.